c-erbB-2, a member of the tyrosine kinase oncogene family, is overexpressed in about 30% of human breast tumors where it correlates with poor prognosis. In vitro studies have suggested that increased expression of the receptor plays an important role in malignant progression. To better understand the direct eects of p185 HER2 overexpression, a human c-erbB-2 expression vector was transfected into the hormone-dependent MCF-7 human breast carcinoma cell line and cell growth was analysed. Unexpectedly, colony formation assay revealed a reduction in the number and size of colonies as compared with mock-transfected cells. In hormone-deprived medium, c-erbB-2 transfected cells acquired growth capability, consistent with previous reports. By contrast, two c-erbB-2-transfected clones grown in complete medium showed a reduced proliferation rate despite the activation of a fully functional oncoprotein capable of autophosphorylation and induction of the MAPK pathway. The number of c-erbB-2-overexpressing cells in the S phase of the cell cycle was about one-half the number of control and mock-transfected cells. Also, overexpression of c-erbB-2 induced overexpression of p21
c-erbB-2, a member of the tyrosine kinase oncogene family, is overexpressed in about 30% of human breast tumors where it correlates with poor prognosis. In vitro studies have suggested that increased expression of the receptor plays an important role in malignant progression. To better understand the direct eects of p185 HER2 overexpression, a human c-erbB-2 expression vector was transfected into the hormone-dependent MCF-7 human breast carcinoma cell line and cell growth was analysed. Unexpectedly, colony formation assay revealed a reduction in the number and size of colonies as compared with mock-transfected cells. In hormone-deprived medium, c-erbB-2 transfected cells acquired growth capability, consistent with previous reports. By contrast, two c-erbB-2-transfected clones grown in complete medium showed a reduced proliferation rate despite the activation of a fully functional oncoprotein capable of autophosphorylation and induction of the MAPK pathway. The number of c-erbB-2-overexpressing cells in the S phase of the cell cycle was about one-half the number of control and mock-transfected cells. Also, overexpression of c-erbB-2 induced overexpression of p21 Introduction c-erbB-2 is a member of the epidermal growth factor receptor (EGFR)-related family of receptor tyrosine kinases (RTKs), which comprises erbB-1, erbB-2, erbB-3 and erbB-4 Dougall et al., 1994) . The four proteins are normally coexpressed in various combinations and can form homo and heterodimers which are activated in response to a number of peptide factors (Wallasch et al., 1995; Beerli et al., 1996; Bacus et al., 1994) . Following ligand binding, RTKs dimerize which leads to activation of the intrinsic protein tyrosine kinase activity and, in turn, to autophosphorylation of the receptor. It has been suggested that receptor overexpression can result in a permanent dimerized state and in the constitutive activation of the kinase, with consequent deregulated transduction of the signal (Yarden et al., 1988) . The Ras signaling pathway was shown to be activated in human breast cancer cells that overexpress the c-erbB-2 receptor (Janes et al., 1994) . In this pathway, the kinase cascade involves Raf, MEK and mitogen-activated protein kinase (MAPK) . An association between overexpression of the 185 Kd c-erbB-2 encoded protein (p185 HER2 ) with both poor prognosis and decreased survival has been reported in breast, ovarian and non-small cell carcinomas (Kern et al., 1994; Felip et al., 1995; Rilke et al., 1991; Slamon et al., 1989) . This association suggests that the deregulated expression of c-erbB-2 may have a profound eect on the development and progression of certain tumors. High level expression of human c-erbB-2 in murine NIH3T3 cells resulted in malignant transformation (Di Fiore et al., 1987) , and transgenic mice bearing normal rat c-erbB-2 under the control of the inducible mouse mammary tumor virus long terminal repeat developed spontaneous breast carcinomas (Guy et al., 1992) . In addition, amplification and overexpression of c-erbB-2 occurs in many tumors of glandular origin, with an incidence as high as 30% in breast tumors (Slamon et al., 1987) . However, there is no direct evidence to indicate a causal relationship between c-erbB-2 overexpression and malignancy, and the prognostic value of p185 HER2 overexpression per se is still controversial. Indeed, p185 HER2 overexpression is frequently associated with several alterations, such as p53 onco-suppressor gene mutations and other clinical and pathological prognostic variables (Poller et al., 1992; Rilke et al., 1991) . Moreover, experimental evidence underlines the importance of heterodimerization with other members of the erbB receptor family in determining the outcome of the transmitted signal (Pinkas-Kramarski et al., 1996; Graus-Porta et al., 1997) .
To analyse the direct eects of p185 HER2 oncoprotein overexpression, we used the hormone-dependent MCF-7 human breast cancer cell line, which expresses low levels of p185
HER2
, in transfection studies. Cells transfected with the normal human c-erbB-2 gene proved to be a suitable model for identifying alterations induced by p185 HER2 overexpression in molecules involved in both signal transduction and control of cell cycle progression. Our data demonstrate that c-erbB-2 overexpression per se in cells grown in complete medium is able to induce growth arrest and dierentiation. These results contribute to the growing body of evidence that c-erbB-2 acts to mediate a network of signals that can elicit both cell proliferation and dierentiation.
Results

c-erbB-2 overexpression inhibits proliferation and induces dierentiation
The cellular alterations induced by p185 HER2 oncoprotein overexpression were investigated in transfected MCF-7 human breast cancer cells.
The overall eect of pcDNA/c-erbB-2 expression on MCF-7 cell growth was evaluated initially by colony formation assay. After transfection followed by 3 weeks of selection in G-418, cells were stained and the number of colonies was counted. c-erbB-2-transfected cells gave rise to a lower number of colonies than did control MCF-7 cells transfected with the empty vector and the colonies were generally smaller. Three independent experiments, performed in duplicate, indicated a decrease of 39+9% (mean+s.d.) in the number of colonies originated from c-erbB-2-transfected cells as compared with that of the mocktransfected control.
Stable transfection was carried out and 30 MCF-7/cerbB-2 clones were isolated and tested for c-erbB-2 expression. Two overexpressing clones, ME#1 and ME#106, were randomly chosen for subsequent studies. Northern blot analysis ( Figure 1A HER2 was estimated by stripping and immunoreacting the same nitrocellulose with antiphosphotyrosine antibody. As shown in Figure 1B (lower bands) a faint signal was detectable from mock cell immunoprecipitates (lane a), while the extent of phosphorylation in both clones ME#1 and ME#106 (lanes b and c, respectively) was comparable with that of control SKBr-3 cells (lane d).
The presence of p185 HER2 on the cell surface was veri®ed by cyto¯uorimetric analysis of live cells. Mean uorescence intensity (+s.d.) of ®ve dierent experiments indicated low amounts of the receptor in mock cells (26+11), whereas clones ME#1 and ME#106 expressed similar amounts of p185 HER2 (424+47 and 382+81, respectively) as SKBr-3 cells (454+89) used as positive control.
Analysis of the in vitro growth properties of the clones by MTT and thymidine incorporation assay indicated that the growth rate of the two clones was signi®cantly decreased in both tests as compared with that of the mock control ( Figure 2 ). Soft agar cloning assay of ME#1 and ME#106 indicated a 39+7% and 49+9% decrease, respectively, in the number of foci as compared with those originating from mock cells (mean of three dierent experiments).
Cell proliferation rates, expressed as the percentage of cells in S-phase of the cell cycle, were determined in mock cells, in ME#1 and in ME#106 grown to 50 ± 60% con¯uence. After propidium iodide staining, the cell cycle distribution was deduced by¯ow cytometry. In three independent experiments, the proportion of cerbB-2-transfectants in S-phase was consistently in the range of 45 ± 54% compared with values for mocktransfected controls. Figure 3 shows a representative experiment in which S-phase cells comprised 25.6% of the mock control population, but only 13.8% and 11.8% of the ME#1 and ME#106 cell populations, respectively.
To determine whether the transfected clones had become hormone-independent as reported for other cerbB-2-transfected breast carcinoma cells (Liu et al., 1995) , thymidine incorporation was also performed in HER2 MAb MGR6, fractionated on a 7.5% polyacrylamide gel and blotted onto nitrocellulose. p185 HER2 was detected using MAb Ab-3 followed by ECL detection. The nitrocellulose ®lter was stripped and washed, and tyrosine-phosphorylated proteins were detected by immunoreaction with anti-phosphotyrosine 4G10 MAb followed by ECL detection. Lanes: (a) mock cells; (b), (c), ME#1 and ME#106 transfectants respectively; (d) SKBr-3 cells c-erbB-2 overexpression and cell-cycle control C Giani et al hormone-deprived medium supplemented with estrogens or not. As shown in Figure 4A , the two clones showed a higher thymidine incorporation than the mock cells in hormone-deprived medium. However, while estrogen supplementation strongly increased thymidine incorporation by mock cells, the p185-overexpressing ME#1 clone maintained the same thymidine incorporation both in presence or absence of estrogens, which was much lower than in the estrogen stimulated mock cells ( Figure 4B ). To determine whether inhibition of cell growth in complete medium was related to induction of dierentiation, we tested for the presence of lipid droplets, which are indicative of a mature phenotype (Bacus et al., 1990) . As shown in Figure 5 , c-erbB-2-transfected ME#106 cells (panel a) produced droplets containing neutral lipids that were not detectable in mock cells (panel b). Transfectants also displayed larger nuclei and sizable¯at cytoplasm, while control cells had a rounded shape and compact nuclei. Similar lipid production and morphological alterations were detected in clone ME#1 (data not shown). Analysis of casein production by cyto¯uorimetry on ®xed cells revealed a mean speci®c¯uorescence intensity in ME#106 that was double the intensity detected in the mock cells (46.9 versus 20.8, respectively).
c-erbB-2 overexpression induces MAPK activation, p21 WAF1 upmodulation and pRb hypophosphorylation Analysis of MAPK phosphorylation status was carried out by Western blot using a phospho-speci®c MAPK antibody, which recognizes the phosphorylated tyrosine at position 204 of p42 MAPK and p44
MAPK
. Figure 6A (upper panel, lanes a, b and c correspond to mock cells, ME#1 and ME#106, respectively) illustrates the presence of the two phosphorylated molecules in cerbB-2-transfectants lysates, while phosphorylation was barely detectable in mock cells, although comparable levels of MAPK proteins were present (lower panel). Thus, c-erbB-2 overexpression induced MAPK activation.
Having assessed alterations in the cell cycle of cerbB-2-transfectants, the cyclin-dependent kinase inhibitor p21 WAF1 was analysed. Western blot analysis revealed expression of the molecule in mock cells and upmodulated expression in c-erbB-2 overexpressing clones ( Figure 6B , lanes a, b and c depict mock cells, ME#1 and ME#106, respectively). Western blot analysis was also used to examine the status of the retinoblastoma protein (pRb) which regulates entry of cells into the S-phase, and revealed a shift in the migration rate of pRb from the two c-erbB-2-transfected clones. Figure 6C shows pRb from ME#1 (lane a) and ME#106 cells (lane b) migrating as a single sharp band at a rate consistent with the hypophosphorylated active form (105 Kd), while lysate from mock-transfected cells (lane c) revealed an additional major band corresponding to the hyperphosphorylated inactive pRb, which reportedly migrates at 115 Kd.
p185
HER2 downmodulation reverses the phenotype
To verify that the alterations observed in transfected cells were indeed c-erbB-2-dependent and not due to clonal variation, c-erbB-2 membrane overexpression c-erbB-2 overexpression and cell-cycle control C Giani et al was inhibited in clone ME#106 by means of intracellular expression of a single chain antibody to c-erbB-2 (scFv-5R) that speci®cally inhibits the transit of p185 HER2 in the endoplasmic reticulum and thus induces the loss of the protein from the cell surface (Beerli et al., 1994) . ME#106 cells were stably transfected with pBabe-5R and the empty vector pBabe-Puro as a control, and the two populations, ME#106-5R and ME#106-Puro, were analysed. As reported in Table 1, p185 HER2 surface expression in ME#106-5R cells was 75% less than the value assessed in ME#106-Puro cells. The decrease in oncoprotein membrane expression paralleled changes in growth rate: assuming as 100% the values obtained in mock cells, thymidine incorporation assay showed that proliferation of ME#106-Puro cells was inhibited by about 50%, whereas ME#106-5R cells showed no inhibition at all. Moreover, cell cycle analysis indicated that the fraction of cells in S-phase increased from 49% in ME#106-Puro to 75% in ME#106-5R cells, as compared with that observed in mock cells.
Western blot analysis also con®rmed the reversion of the c-erbB-2-induced phenotype. As shown in Figure 7 
Discussion
Thus far, c-erbB-2 overexpression, a frequent event in several human cancers, including breast tumors, has been correlated with a poor prognosis (Kern et al., 1994; Felip et al., 1995; Rilke et al., 1991; Slamon et al., 1989) . In addition, in vitro studies have shown that transfection of p185 HER2 can induce proliferation and a malignant phenotype (Liu et al., 1995; Di Fiore et al., 1987) .
The present study shows that the exogenous overexpression of the c-erbB-2 gene by hormonedependent MCF-7 human breast cancer cells inhibits proliferation and induces dierentiation of these cells. Indeed, transfection of the oncogene resulted in reduction of plating and cloning eciency, decreased growth rate, increased p21 WAF1 expression and production of lipid droplets.
Receptor tyrosine kinases (RTKs) are known to be involved in signaling pathways for both cell proliferation and cell dierentiation (Schlessinger et al., 1992) . Despite several clinical and experimental observations indicating a role for p185 HER2 overexpression in the growth of breast carcinoma, it is unknown whether the physiological function of p185 HER2 is to promote proliferation or dierentiation in vivo. p185 HER2 protein levels have been shown to increase during the last steps of functional development of the normal mammary gland in pregnant rats (Kokai et al., 1987) , suggesting a role for c-erbB-2 in the functional dierentiation of mammary cells. In vitro, Mabs against p185 HER2 or heregulin were found to induce either proliferation (Holmes et al., 1992) or dierentiation (Peles et al., 1992) .
In breast carcinoma cell lines, c-erbB-2-transfection was found to reduce hormone-dependence (Liu et al., 1995) . Consistent with this observation, our c-erbB-2-transfected cells were found to grow more vigorously than the mock cells in the absence of hormones. However, our study shows that in hormone-dependent cells such as MCF-7, grown in the presence of hormones, c-erbB-2 overexpression inhibits proliferation and induces dierentiation. This suggests that in the presence of hormones, the p185 HER2 -signaling pathway is switched towards dierentiation.
The cross-signaling pathway between estrogen receptors (ERs) and RTKs is largely unknown. In light of reports that estradiol induces a rapid MAPK activation (Endoh et al., 1997; Watters et al., 1997) and that a sustained rather than a transient activation of MAPK triggers dierentiation instead of proliferation (Traverse et al., 1992; , we speculate that the presence of both growth factor and hormonal signaling pathways in the same cell induces dierentiation by Figure 7 Reversion of the c-erbB-2 induced phenotype by scFv-5R transfection. Cell lysates (100 mg) were resolved on a 5 ± 15% gradient SDS polyacrylamide gel and blotted. Filters were immunoreacted with anti-phospho-speci®c MAPK and anti-ERK 2 (A), anti-p21 waf (B) and anti-pRb (C). In all panels, lanes (a), (b) and (c) correspond to mock cells, ME#106-Puro and ME#106-5R, respectively Figure 6 Protein expression pro®le of c-erbB-2-transfected cells as compared with mock-transfected cells. Cells were lysed and 100 mg of total lysate was resolved on a 10% (A), 15% (B) or 7.5% (C) SDS-polyacrylamide gel. Blotted ®lters were immunoreacted with anti-phospho-speci®c MAPK Ig, which recognizes the phosphorylated form of p42 MAPK and p44 MAPK proteins, and with anti-ERK 2 Ig, which recognizes p42
MAPK and, to a lesser extent, p44 MAPK (A), anti-p21WAF WAF1 (B) and anti-pRb (C). In A and B, lanes (a), (b) and (c) correspond to mock cells, ME#106 and ME#1, respectively, whereas in C, they correspond to ME#1, ME#106 and mock cells, respectively. Reactions were visualized by the ECL technique c-erbB-2 overexpression and cell-cycle control C Giani et al increasing the duration of MAPK activation. This dierentiation is associated with increased expression of p21 WAF1 and the dramatic dephosphorylation of the retinoblastoma protein pRb. As widely reported, p21 WAF1 belongs to a class of regulatory proteins that inhibit the action of cyclin-dependent kinases in cell cycle progression (Xiong et al., 1993) and pRb acts in the G1-phase of the cell cycle, regulating the expression of a bank of genes that mediate progression of the cell through the growth cycle (Paggi et al., 1995) . Several lines of evidence indicate that both p21 WAF1 and pRb may also play a positive role in the dierentiation of a variety of cell types (Stein et al., 1990; Chen et al., 1995; Wang et al., 1996; Parker et al., 1995; Yang et al., 1995) . Our data are consistent with the previously reported association between phenylacetate-induced growth arrest in MCF-7 cells and enhanced expression of p21 WAF1 and dephosphorylation of the retinoblastoma protein where p21 WAF1 induction was required for accumulation of the hypophosphorylated pRb (Gorospe et al., 1996) . Moreover, Bacus et al. (1996) showed that in MCF7 cells grown in complete medium, heregulin and antibodies to p185 HER2 upregulate the expression of p21
WAF1
. Therefore, the stimulus arising from p185
HER2 activation may confer a proliferative advantage in hormone-dependent cells only in the absence of hormones or in hormone-independent cells. In accord with this mechanism, c-erbB-2 overexpression in breast carcinomas, indicative of proliferation (Rilke et al., 1991) , is strongly associated with the absence of hormone receptor expression (Todd et al., 1992) .
In conclusion, our results show that c-erbB-2 overexpression can in¯uence MAPK and pRb phosphorylation levels, upmodulate p21 WAF1 , inhibit growth rate and induce dierentiation. These phenomena were due to the increased expression of the oncoprotein, as proven by the reversion of the phenotype when translocation of the receptor to the membrane was inhibited.
Our ®ndings indicate that c-erbB-2 overexpression is not always related to an increase in cell proliferation. The clinical association of c-erbB-2 with poor prognosis in cancer patients may depend on alterations in the physiological hormonal signaling pathway, and the decrease survival of c-erbB-2-positive tumor patients treated with tamoxifene as compared to untreated patients (Carlomagno et al., 1996) might depend in part of the inhibition of the cross-talk between the two receptors.
Materials and methods
Cells and culture conditions
All cell lines were obtained from ATCC (Rockville, MD) and maintained at 378C in a humidi®ed atmosphere of 5% CO 2 in air. Human breast adenocarcinoma cell lines MCF-7 and SKBr-3 were routinely cultured in RPMI-1640 medium (Sigma, St Louis, MO) supplemented with 10% heat-inactivated FCS (HyClone, Logan, UT) and 2 mM Lglutamine. MCF-7 cells transfected with pcDNA1/neo or pcDNA/c-erbB-2 were cultured as above, except that the culture medium also contained 500 mg/ml G-418 (geneticin, Gibco BRL, Paisley, UK). MCF-7 cells transfected with pBabe-Puro or pBabe-5R also required the addition of 2 mg/ml puromycin (Sigma).
Plasmids
Full length human c-erbB-2 cDNA was excised from LTR-2/erbB-2 expression vector, kindly provided by Dr P Di Fiore (Di Fiore et al., 1987) , by digestion with XhoI (Boehringer Mannheim, GmbH, Germany). The fragment was subcloned into the XhoI restriction site of pcDNA1/ neo plasmid (Invitrogen, San Diego, CA), under the control of the cytomegalovirus immediate early gene promoter. pBabe-Puro and pBabe-5R (Beerli et al., 1994) were a generous gift from Nancy Hynes.
Transfections
Cells at 80% con¯uence in serum-free medium were transfected only with 50 mg of Lipofectin (Gibco BRL) for selection control, or with 50 mg of Lipofectin plus 20 mg of plasmid. Transfectants were left overnight at 378C and, after replacement of the complete medium, maintained in culture for an additional 48 h. For stable transfection, cells were trypsinized and plated in the presence of the selecting compounds until all control cells were dead. Individual colonies were picked, expanded and maintained in the presence of the selecting agents. MCF-7 cells transfected with pcDNA1/neo were designated`mock', and those transfected with pcDNA/c-erbB-2 were designated`ME'. Cells were selected with 500 mg/ml of G-418 or for cells transfected with pBabe-Puro or pBabe-5R, with 2 mg/ml of puromycin.
Colony assays
MCF-7 cells were stably transfected with either pcDNA1/ neo or pcDNA1/c-erbB-2 plasmid and plated (10 6 cells/ plate) in duplicate. After 3 weeks of selection in 500 mg/ml of G-418, plates were stained with TB methylene blue for 15 min (Difco, Detroit, MI).
Northern blot analysis
RNA was extracted as described (Sambrook et al., 1989) . 10 mg/sample of RNA was electrophoresed in 1% agaroseformaldehyde gel, transferred onto nitrocellulose ®lters (Schleicher & Schuell, Keene, NH) and immobilized by UV-crosslinking. Hybridization was carried out using a dCTP (Amersham, Little Chalfont, UK) random-primed (Boehringer) probe, obtained by XhoI digestion of LTR-2/ c-erbB-2 plasmid. After stripping, membranes were hybridized with a control dCTP b-actin probe (Gunning et al., 1983) .
Western blot analysis
Cells were scraped and lysed for 45 min on ice in 50 mM Tris-HCl, pH 7.4, 1% NP40, 10 mg/ml leupeptin, 1 mM PMSF and 1 mM Na 3 VO 4 . Cell lysates were cleared by centrifugation. Protein concentration was determined by the BCA protein assay reagent (Pierce Biochemical Company, St. Louis, MO). For each sample, 100 mg of total protein extract were electrophoresed in a polyacrylamide gel according to Laemmli (1970) . For immunoprecipitations, 1 mg of total cell lysate was incubated for 1 h at 48C with 10 mg of anti-p185 HER2 MAb MGR6 (Centis et al., 1992) and 1 h at 48C with protein A-Sepharose (Pharmacia). Immune complexes were washed three times with lysis buer, eluted and denatured by heating for 5 min at 958C in reducing Laemmli buer and resolved in a polyacrylamide gel. Separated proteins were electrophoretically transferred to a nitrocellulose membrane (Hybond C, Amersham) and incubated for 2 h with the primary antibody followed by incubation with labeled secondary antibody (Amersham) and autoradiography, or by incubation with biotinylated secondary antibody (1 : 200, Amersham) followed by incubation with streptavidinbiotinylated horseradish peroxidase complex (1 : 100, Amersham) and visualized using the ECL detection system (Amersham). When necessary, ®lters were stripped in 62.5 mM Tris-HCl, 2% SDS and 100 mM b-mercaptoethanol for 30 min at 658C, washed overnight and immunoreacted again. Antibodies used were: anti-p185 HER2 Ab-3 (1 mg/ml; Oncogene Science, Cambridge, MA), antiphosphotyrosine 4G10 (4 mg/ml; Upstate Biotechnology, Inc., Lake Placid, NY), anti-pRb Ab-5 (1 mg/ml; Oncogene Science), anti-phospho-speci®c MAPK (1 : 1000; New England Biolabs, Beverly, MA), anti-ErK2 C-14 (1 mg/ml; Santa Cruz Biotechnology, Santa Cruz, CA) and anti-p21 AB-3 (1 mg/ml; NeoMarkers, Fremont, CA).
Flow cytometric analysis
Detached cells were incubated for 45 min at 08C with MAb MGR6 (10 mg/ml), or with anti casein-antibody (1 mg/ml; Harlan, Sera-Lab, UK) in PBS containing 0.03% bovine serum albumin. After several washings, cells were further incubated for 45 min at 08C with¯uorescein-linked goat anti-mouse antibody (Kierkegard and Perry Labs, Gaithersburg, MD). After washing, cell¯uorescence was measured using a FACScan¯ow cytometer with LYSIS TM II software (Becton-Dickinson, Mountain View, CA).
Proliferation assays
Control and transfected cells were seeded in 96-well plates. After 1, 2, 4, 6 and 7 days of culture, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dye (5 mg/ml) in PBS was added in doses of 10 ml/well for 4 h. Cells were then treated with 2-propanol to dissolve blue formazan crystals and spectrophotometrically evaluated at a wavelength of 570 nm. Each experiment was performed on six dierent wells per cell line.
Cells were incubated with 1 mCi/well thymidine (Amersham) for 4 h and washed with cold PBS. Following 2 h incubation on ice with 10% trichloracetic acid, cells were lysed for 30 min in 100 ml of 0.2 N NaOH, 1% SDS. The reaction was blocked by adding 100 ml of 0.2 N HCl and radioactivity was counted in the b-counter.
Estrogen-controlled experiments were performed on cells cultured for 6 days in medium without Phenol Red and with fetal calf serum stripped by charcoal suspension (0.5% charcoal, 0.05% dextran in 10 mM Tris). When indicated, 1 nM b-estradiol (Sigma) was added to the medium.
Soft agar assay
Cells (5610 3 cells/well) were seeded in 6-well plates in semisolid medium containing 0.3% Bacto Agar (Difco) supplemented with 30% FCS and 300 mg/ml G418, over a 0.6% agarose layer. Colonies were scored after 3 weeks of incubation at 378C in 5% CO 2 in air.
Cell cycle analysis
Exponentially growing cells were trypsinized, ®xed in 0.5% paraformaldehyde for 5 min, permeabilized in 0.1% Triton X-100 and incubated at 378C for 30 min in the presence of RNAse A (1 mg/ml; Sigma). DNA staining was performed at 08C by 30 min incubation with propidium iodide (50 mg/ ml) in PBS containing 0.03% bovine serum albumin. Fluorescence was measured using a FACScan¯ow cytometer with LYSIS TM II software, and the data were analysed with CellFIT software (all Becton-Dickinson).
Lipid visualization
Neutral lipids were visualized using a modi®cation of the Oil Red O in propylene glycol method (Bacus et al., 1990) . Brie¯y, cells grown on Lab-Tek slides were ®xed by a quick dip in 7208C methanol/acetate (v/v) and incubated at room temperature in absolute propylene glycol for 5 min. Cells were then stained for 7 min in Oil Red O solution, dipped into 85% isopropanol, counterstained for 3 min in Mayer's hematoxylin and mounted in glycerol.
